ARCHIVES

Amgen Website Invites Testimonials, Posts Off-Label Claims By Patients.

This article is from The Cancer Letter archive.

Vol. 33 No. 41 | November 9, 2007

Download PDF Visit The Full Archive

Related Articles

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

White House Seek Elimination Of NCI’s Bypass Budget Authority In Legislation Renewing Cancer Act

April 9, 1982

Racial Disparities Remain In Breast Cancer Care

October 29, 2010

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

‘Meta-analysis’ Of Early Breast Cancer Trials finds Adjuvant Therapy Significantly Prolongs Life

January 10, 1992